News

Press Releases
Date	Title (click to view)
October 9, 2008	Alte Biosciences to Present Depression and Gastrointestinal Disorder Treatments at 2008 SEBIO
September 3, 2008	Alte Biosciences Files Patent for New Inflammatory Bowel Disease Drugs
October 16, 2007	Alte Biosciences Announces License Deal with Duke University for Treatment of Vascular Depression

 

Milestones and Accomplishments
2003	Alte Biosciences founded
2004	Provisional patent application for Oraleze™ filed
2005	PCT patent application for Oraleze™ filed
2007	Licensed IP from Duke University Medical Center covering the use of methyl xanthines in the treatment of Vascular Depression and related disorders
	Formed Alte Therapeutics to develop Vascular Depression asset
	US patent application for improved Oraleze™ filed
2008	Multiple invention disclosures for treatments of inflammatory bowel disease and rheumatoid arthritis prepared and US Patent Applications initiated
	In-licensed rights to develop and commercialize a unique packaging system for acid stabilized drugs